Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. The company is headquartered in Seattle, Washington and currently employs 25 full-time employees. The firm focuses on addressing the global smoking health and nicotine dependence epidemic through the development and commercialization of cytisinicline. The company has completed two Phase III studies with cytisinicline for smoking cessation and one Phase II study with cytisinicline in vaping cessation. Cytisinicline is a naturally occurring, plant-based alkaloid. Cytisinicline is structurally similar to nicotine and has a dual-acting mechanism of action, being both a receptor agonist and antagonist. Cytisinicline is an investigational product candidate being developed for the treatment of nicotine dependence and has not been approved by the Food and Drug Administration for any indication in the United States. Cytisinicline acts as a partial agonist/antagonist, binding to alpha-4 beta-2 nicotinic receptors in the brain and is thought to have two potential consequences in treating nicotine dependence.
How did ACHV's recent EPS compare to expectations?
The most recent EPS for Achieve Life Sciences Inc is $-0.28, beating expectations of $-0.26.
How did Achieve Life Sciences Inc ACHV's revenue perform in the last quarter?
Achieve Life Sciences Inc revenue for the last quarter is $-0.28
What is the revenue estimate for Achieve Life Sciences Inc?
According to 5 of Wall street analyst, the revenue estimate of Achieve Life Sciences Inc range from $0.0 to $0.0
What's the earning quality score for Achieve Life Sciences Inc?
Achieve Life Sciences Inc has a earning quality score of B+/55.439774. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Achieve Life Sciences Inc report earnings?
Achieve Life Sciences Inc next earnings report is expected in 2026-02-04
What are Achieve Life Sciences Inc's expected earnings?
Achieve Life Sciences Inc expected earnings is $0.0, according to wall-street analysts.
Did Achieve Life Sciences Inc beat earnings expectations?
Achieve Life Sciences Inc recent earnings of $0.0 does not beat expectations.